Acorah Software Products - Accounts Production 19.3.600 false true false true No description of principal activity 1 April 2025 31 March 2026 31 March 2026 16237476 Dr Natalie Forshaw iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16237476 2025-03-31 16237476 2026-03-31 16237476 2025-04-01 2026-03-31 16237476 frs-core:CurrentFinancialInstruments 2026-03-31 16237476 frs-bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 16237476 frs-bus:FilletedAccounts 2025-04-01 2026-03-31 16237476 frs-bus:Micro-entities 2025-04-01 2026-03-31 16237476 frs-bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 16237476 frs-bus:Director1 2025-04-01 2026-03-31
Registered number: 16237476
Natalie Forshaw Limited
Unaudited Financial Statements
For The Year Ended 31 March 2026
Sharpe Medical Accounting Ltd
Balance Sheet
Registered number: 16237476
2026
£
Current assets 21,588
Creditors: Amounts Falling Due Within One Year (5,990 )
NET CURRENT ASSETS 15,598
TOTAL ASSETS LESS CURRENT LIABILITIES 15,598
Accruals and deferred income (600 )
NET ASSETS 14,998
CAPITAL AND RESERVES 14,998

Notes

1. General Information
Natalie Forshaw Limited is a private company, limited by shares, incorporated in England & Wales, registered number 16237476 . The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, DN15 9YG.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
Page 0
Page 1
For the year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Dr Natalie Forshaw
Director
02/10/2026